169 related articles for article (PubMed ID: 31878900)
1. Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: a meta-analysis and system review.
Jiang SS; Deng B; Feng YG; Qian K; Tan QY; Wang RW
BMC Pulm Med; 2019 Dec; 19(1):262. PubMed ID: 31878900
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Fan G; Zhang K; Ding J; Li J
Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis.
Wang J; Wang K; Xu J; Huang J; Zhang T
PLoS One; 2013; 8(11):e78070. PubMed ID: 24223761
[TBL] [Abstract][Full Text] [Related]
7. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
Bozkaya Y; Kurt B; Gürler F
Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
[TBL] [Abstract][Full Text] [Related]
8. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
Salgia R; Weaver RW; McCleod M; Stille JR; Yan SB; Roberson S; Polzer J; Flynt A; Raddad E; Peek VL; Wijayawardana SR; Um SL; Gross S; Connelly MC; Morano C; Repollet M; Sanders R; Baeten K; D'Haese D; Spigel DR
Invest New Drugs; 2017 Jun; 35(3):334-344. PubMed ID: 28299514
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of circulating tumor cells in small--cell lung cancer patients: a meta-analysis.
Zhang J; Wang HT; Li BG
Asian Pac J Cancer Prev; 2014; 15(19):8429-33. PubMed ID: 25339041
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis.
Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H
Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells count as a predictor of survival in lung cancer.
Syrigos K; Fiste O; Charpidou A; Grapsa D
Crit Rev Oncol Hematol; 2018 May; 125():60-68. PubMed ID: 29650278
[TBL] [Abstract][Full Text] [Related]
14. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients.
Li Y; Cheng X; Chen Z; Liu Y; Liu Z; Xu S
Sci Rep; 2017 Jul; 7(1):4971. PubMed ID: 28694485
[TBL] [Abstract][Full Text] [Related]
17. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
18. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.
Aguiar-Bujanda D; Dueñas-Comino A; Saura-Grau S; Ros-Sanjuan L; Blanco-Sanchez MJ; Hernandez-Sosa M; Mori-De Santiago M; Galvan-Ruiz S; Lorenzo-Barreto JE; Vargas-Prado AM; Bohn-Sarmiento U
Oncol Res Treat; 2018; 41(12):755-761. PubMed ID: 30419558
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer.
Wu ZX; Liu Z; Jiang HL; Pan HM; Han WD
Oncotarget; 2016 Oct; 7(41):67586-67596. PubMed ID: 27588489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]